116 related articles for article (PubMed ID: 38829967)
1. Impact of the Early COVID-19 Pandemic on Incidence and Outcomes of Hepatocellular Carcinoma in the United States.
Liang J; Lee YT; Yeo YH; Luu M; Ayoub W; Kuo A; Trivedi H; Vipani A; Gaddam S; Kim H; Wang Y; Rich N; Kosari K; Nissen N; Parikh N; Singal AG; Yang JD
Clin Transl Gastroenterol; 2024 Jun; ():. PubMed ID: 38829967
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular Carcinoma Incidence and Mortality in the USA by Sex, Age, and Race: A Nationwide Analysis of Two Decades.
Abboud Y; Ismail M; Khan H; Medina-Morales E; Alsakarneh S; Jaber F; Pyrsopoulos NT
J Clin Transl Hepatol; 2024 Feb; 12(2):172-181. PubMed ID: 38343612
[TBL] [Abstract][Full Text] [Related]
3. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.
Altekruse SF; McGlynn KA; Reichman ME
J Clin Oncol; 2009 Mar; 27(9):1485-91. PubMed ID: 19224838
[TBL] [Abstract][Full Text] [Related]
5. Racial disparities in treatment and survival of patients with hepatocellular carcinoma in the United States.
Xu L; Kim Y; Spolverato G; Gani F; Pawlik TM
Hepatobiliary Surg Nutr; 2016 Feb; 5(1):43-52. PubMed ID: 26904556
[TBL] [Abstract][Full Text] [Related]
6. Trends in hepatocellular carcinoma stage by racial/ethnic group in the United States, 1992-2019.
Alvarez CS; Ruhl J; Flynn G; Graubard BI; McGlynn KA
JHEP Rep; 2023 Nov; 5(11):100868. PubMed ID: 37799980
[TBL] [Abstract][Full Text] [Related]
7. Racial and Ethnic Disparities in Survival Among Patients With Hepatocellular Carcinoma in the United States: A Systematic Review and Meta-Analysis.
Rich NE; Carr C; Yopp AC; Marrero JA; Singal AG
Clin Gastroenterol Hepatol; 2022 Feb; 20(2):e267-e288. PubMed ID: 33387668
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.
White DL; Thrift AP; Kanwal F; Davila J; El-Serag HB
Gastroenterology; 2017 Mar; 152(4):812-820.e5. PubMed ID: 27889576
[TBL] [Abstract][Full Text] [Related]
9. Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival.
Sloane D; Chen H; Howell C
J Natl Med Assoc; 2006 Dec; 98(12):1934-9. PubMed ID: 17225837
[TBL] [Abstract][Full Text] [Related]
10. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.
Altekruse SF; Henley SJ; Cucinelli JE; McGlynn KA
Am J Gastroenterol; 2014 Apr; 109(4):542-53. PubMed ID: 24513805
[TBL] [Abstract][Full Text] [Related]
11. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
Ding J; Wen Z
BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
[TBL] [Abstract][Full Text] [Related]
12. Racial and Sex Disparities in Hepatocellular Carcinoma in the USA.
Ajayi F; Jan J; Singal AG; Rich NE
Curr Hepatol Rep; 2020 Dec; 19(4):462-469. PubMed ID: 33828937
[TBL] [Abstract][Full Text] [Related]
13. Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States.
Lee IS; Okumura K; Misawa R; Sogawa H; Veillette G; John D; Diflo T; Nishida S; Dhand A
World J Hepatol; 2023 Apr; 15(4):554-563. PubMed ID: 37206654
[TBL] [Abstract][Full Text] [Related]
14. State-Level HCC Incidence and Association With Obesity and Physical Activity in the United States.
Lee YT; Wang JJ; Luu M; Tseng HR; Rich NE; Lu SC; Nissen NN; Noureddin M; Singal AG; Yang JD
Hepatology; 2021 Sep; 74(3):1384-1394. PubMed ID: 33728665
[TBL] [Abstract][Full Text] [Related]
15. Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018.
Alvarez CS; Petrick JL; Parisi D; McMahon BJ; Graubard BI; McGlynn KA
Hepatology; 2022 Sep; 76(3):589-598. PubMed ID: 35124828
[TBL] [Abstract][Full Text] [Related]
16. Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States.
Konyn P; Perumpail BJ; Wijarnpreecha K; Cholankeril G; Ahmed A; Kim D
Expert Rev Gastroenterol Hepatol; 2024; 18(1-3):113-119. PubMed ID: 38353612
[TBL] [Abstract][Full Text] [Related]
17. Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United States.
Ahn JC; Lauzon M; Luu M; Noureddin M; Ayoub W; Kuo A; Sundaram V; Kosari K; Nissen N; Gong J; Hendifar A; Roberts LR; Abou-Alfa GK; Singal AG; Yang JD
Hepatology; 2022 Dec; 76(6):1649-1659. PubMed ID: 35429171
[TBL] [Abstract][Full Text] [Related]
18. Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: Nationwide multigenerational cohort study.
Ebrahimi F; Hagström H; Sun J; Bergman D; Shang Y; Yang W; Roelstraete B; Ludvigsson JF
J Hepatol; 2023 Dec; 79(6):1374-1384. PubMed ID: 37647992
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States.
Rich NE; Yopp AC; Singal AG; Murphy CC
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):242-248.e5. PubMed ID: 31042582
[TBL] [Abstract][Full Text] [Related]
20. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
